GNPX 2017 Annual Report

24 The results of this preclinical study indicate that TUSC2-sensitization to anti-PD1 could be produced in both Kras-mutant lung cancer mouse models. 14-Therapeutic Efficacy of TUSC2+Anti-PD1 in a Lung Metastasis Model (Large)